Blood DNA patterns flag early cancers in computer tests
In cross-validation tests using two datasets, Blackjack detected at least 91.8% of cancers while correctly identifying 98% of healthy samples.
Our read
Biomarkers- Studied:
- Preprint: computational study of healthy individuals and people with cancer
- What changed:
- Blackjack detected 89.8% of stage I cancers in cross-validation tests
- The catch:
- Detection accuracy during routine cancer screening was not measured
Editor of record: Boris Djordjevic · AgingResearch.News
DNA fragments circulating in the blood of healthy individuals and people with cancer were analyzed in a computational study using two external DNA-sequencing datasets. The approach, called Blackjack, compared patterns in DNA sequences around fragment ends with patterns from known healthy and cancer groups. It used two measures of similarity to classify each sample.
In cross-validation, the method learned from part of the data and was tested on other samples. It detected 89.8% of stage I cancers and 90.2% of stage II cancers. Across eight cancer types, the lowest sensitivity—the share of cancers detected—was 80.0%. Accuracy also remained stable when the researchers simulated low amounts of sequencing data.
Why it matters
Cancer screening is relevant to healthy aging. This work explores whether blood-borne DNA could support less invasive tests for several cancers.
Caveats
Cross-validation in existing datasets leaves open how well the method would perform in people undergoing routine cancer screening. The findings appeared in a medRxiv preprint and have not been peer-reviewed.
The paper
Blackjack Biotechnologies
medRxiv, Nov 10, 2026, Open access, Preprint, not yet peer-reviewed
Comments
Be the first to comment.